Linaclotide use is not recommended in the following patients:

- Pediatric patients less than two years of age, as they are at risk of developing severe dehydrationÂ - in nonclinical studies, deaths due to diarrhea and severe dehydration were reported following orally administered linaclotide in neonatal mice

- Patients with known or suspected mechanical obstruction of the gastrointestinal tract.

- Patients who have experienced hypersensitivity reactions to linaclotide or any of the components of its formulation

Moreover, clinical trials have not been conducted to establish the safety and effectiveness of linaclotide in patients aged younger than 18 years.